Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Other Operating Expenses: 2019-2020

Historic Other Operating Expenses for Beam Therapeutics (BEAM) over the last 2 years, with Dec 2020 value amounting to -$61.8 million.

  • Beam Therapeutics' Other Operating Expenses rose 43.56% to -$1.2 million in Q1 2021 from the same period last year, while for Mar 2021 it was -$60.9 million, marking a year-over-year decrease of 1102.69%. This contributed to the annual value of -$61.8 million for FY2020, which is 1849.31% down from last year.
  • Per Beam Therapeutics' latest filing, its Other Operating Expenses stood at -$61.8 million for FY2020, which was down 1,849.31% from -$3.2 million recorded in FY2019.
  • In the past 5 years, Beam Therapeutics' Other Operating Expenses ranged from a high of -$3.2 million in FY2019 and a low of -$61.8 million during FY2020.
  • Over the past 2 years, Beam Therapeutics' median Other Operating Expenses value was -$32.5 million (recorded in 2019), while the average stood at -$32.5 million.
  • Data for Beam Therapeutics' Other Operating Expenses shows a maximum YoY tumbled of 1,849.31% (in 2020) over the last 5 years.
  • Over the past 2 years, Beam Therapeutics' Other Operating Expenses (Yearly) stood at -$3.2 million in 2019, then crashed by 1,849.31% to -$61.8 million in 2020.